1. Wallen EM, Pruthi RS, Joyce GF, Wise M. Urologic Diseases in America Project. Kidney cancer. J Urol 2007; 177 (6): 2006–18 (discussion 2018–9).
2. Woldrich JM, Mallin K, Ritchey J et al. Sex differences in renal cell cancer presentation and survival: an analysis of the National Cancer Database, 1993–2004. J Urol 2008; 179 (5): 1709–13 (discussion 1713).
3. Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma.
4. Levi F, Ferlay J, Galeone C. The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int 2008; 101 (8): 949–58.
5. Robson CJ. Radical nephrectomy for renal cell carcinoma. J Urol 1963; 89: 37–41.
6. Robson CJ, Churchill BM, Andersen W. Theresults of radical nephrectomy for renal cell carcinoma. J Urol 1969; 101: 297–301.
7. Wells S. Successful removal of two solid circum-renal tumors. Br Med J 1884; 1: 758.
8. Czerny H.E. UeberNierenexstirpation. Beitr Z Klin Chir 1890; 6: 484–6.
9. Vermooten V. Indications for conservative surgery in certain renal tumors: a study based on the growth pattern of the clear-cell carcinoma. J Urol 1950; 64: 200–21.
10. Rendon RA, Jewett MA. Expectant management for the treatment of small renal masses. Urol Oncol 2006; 24 (1): 62–7.
11. Schlomer B, Figenshau RS, Yan Y et al. Pathological features of renal neoplasms classified by size and symptomatology. J Urol 2006; 176 (4 Pt 1): 1317–20 (discussion 1320).
12. Ljunberg B, Hanbury DC, Kuczyk MA. Guidelines on renal cell carcinoma. European Association of Urology, 2007; p. 14.
13. Patard JJ, Shvarts O, Lam JS. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 2004; 171 (6 Pt 1): 2181–5.
14. Li QL, Cheng L, Guan HW. Safety and efficacy of mini-margin nephron-sparing surgery for renal cell carcinoma 4-cm or less. Urology 2008; 71 (5): 924–7.
15. Timsit MO, Bazin JP, Thiounn N. Prospective study of safety margins in partial nephrectomy: intraoperative assessment and contribution of frozen section analysis. Urology 2006; 67 (5): 923–6.
16. Yossepowitch O, Thompson RH, Leibovich BC. Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol 2008; 179 (6): 2158–63.
17. Bensalah K, Pantuck AJ, Rioux-Leclercq N. Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol 2010; 57 (3): 466–71.
18. Bielsa O, Lloreta J, Gelabert-Mas A. Cystic renal cell carcinoma: pathological features, survival and implications for treatment. Br J Urol 1998; 82 (1): 16–20.
19. Webster WS, Thompson RH, Cheville JC et al. Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma. Urology 2007; 70 (5): 900–4.
20. Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur Urol 2006; 49 (5): 798–805.
21. Dalla-Palma L, Pozzi-Mucelli F, di Donna A, Pozzi-Mucelli RS. Cystic renal tumors: US and CT findings. Urol Radiol 1990; 12 (2): 67–73.
22. Dimitrios V, Thierry L, Vincent M et al. Cystic renal cell carcinoma: histological features and clinical outcome. Eur Urol 2002 (Suppl. 1); 1: 172; J Urol 2006; 176 (6 Pt 1): 2353–8.
23. Murad T, Komaiko W, Oyasu R, Bauer K. Multilocular cystic renal cell carcinoma. Am J Clin Pathol 1991; 95: 633–7.
24. Серегин А.В. Органосохраняющие операции при раке почки. Дис. … д-ра мед. наук. М., 2000.
25. Школьник М.И., Прохоров Д.Г., Леоненков Р.В., Шевцов И.В. Современные методы гемостаза при органосохраняющих операциях по поводу рака почки. Онкохирургия. 2009; 1: 32–5.
26. Петров С.Б., Шпиленя Е.С., Кукушкин А.В., Шкарупа Д.Д. Усовершенствованная техника достижения гемостаза при резекции почки с новообразованием. Онкоурология. 2009; 1: 14–9.